| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/25/2023 | 29.87% | Jefferies | $3 → $1 | Downgrades | Buy → Hold |
| 07/20/2023 | 29.87% | Goldman Sachs | $1.5 → $1 | Maintains | Sell |
| 07/19/2023 | 62.34% | Northland Capital Markets | $2 → $1.25 | Maintains | Market Perform |
| 01/06/2023 | 289.61% | Jefferies | $1.3 → $3 | Upgrades | Hold → Buy |
| 10/19/2022 | 159.74% | SVB Leerink | $3 → $2 | Maintains | Market Perform |
| 05/24/2022 | 94.81% | Goldman Sachs | $1.75 → $1.5 | Maintains | Sell |
| 05/06/2022 | — | JP Morgan | Downgrades | Neutral → Underweight | |
| 05/05/2022 | 289.61% | HC Wainwright & Co. | $10 → $3 | Downgrades | Buy → Neutral |
| 05/05/2022 | 289.61% | SVB Leerink | $10 → $3 | Downgrades | Outperform → Market Perform |
| 02/16/2022 | 1198.7% | SVB Leerink | $11 → $10 | Maintains | Outperform |
| 01/31/2022 | 1328.57% | SVB Leerink | $12 → $11 | Maintains | Outperform |
| 09/09/2021 | 1458.44% | SVB Leerink | → $12 | Initiates Coverage On | → Outperform |
| 05/12/2021 | 549.35% | Goldman Sachs | $6 → $5 | Downgrades | Neutral → Sell |
| 02/01/2021 | 1977.92% | SVB Leerink | $12 → $16 | Maintains | Outperform |
| 09/28/2020 | 1458.44% | SVB Leerink | $9 → $12 | Maintains | Outperform |
| 08/26/2020 | 2627.27% | Piper Sandler | → $21 | Initiates Coverage On | → Overweight |
| 05/04/2020 | 1328.57% | Aegis Capital | $9 → $11 | Maintains | Buy |
| 05/04/2020 | 1068.83% | SVB Leerink | $7 → $9 | Maintains | Outperform |
| 04/01/2020 | 679.22% | Citigroup | $24 → $6 | Maintains | Buy |
| 03/31/2020 | 938.96% | Stifel | $24 → $8 | Maintains | Hold |
| 03/31/2020 | — | Oppenheimer | Upgrades | Underperform → Perform | |
| 03/31/2020 | 419.48% | Goldman Sachs | $27 → $4 | Downgrades | Buy → Neutral |
| 03/31/2020 | 419.48% | Jefferies | $30 → $4 | Downgrades | Buy → Hold |
| 03/13/2020 | 3536.36% | Goldman Sachs | → $28 | Upgrades | Neutral → Buy |
| 03/02/2020 | 2887.01% | Cowen & Co. | → $23 | Initiates Coverage On | → Outperform |
| 02/26/2020 | 1458.44% | Oppenheimer | $13 → $12 | Maintains | Underperform |
| 02/18/2020 | 3016.88% | Citigroup | $27 → $24 | Upgrades | Neutral → Buy |
| 01/06/2020 | 2757.14% | JP Morgan | → $22 | Initiates Coverage On | → Neutral |
| 12/16/2019 | 938.96% | Oppenheimer | $7 → $8 | Maintains | Underperform |
| 12/16/2019 | 3276.62% | Stifel | $28 → $26 | Downgrades | Buy → Hold |
| 11/20/2019 | 809.09% | Oppenheimer | → $7 | Initiates Coverage On | → Underperform |
| 11/18/2019 | 3406.49% | Citigroup | $23 → $27 | Downgrades | Buy → Neutral |
| 10/31/2019 | 2887.01% | Aegis Capital | → $23 | Initiates Coverage On | → Buy |
| 10/15/2019 | 2107.79% | Goldman Sachs | → $17 | Initiates Coverage On | → Neutral |
| 03/22/2019 | 3406.49% | Stifel | → $27 | Initiates Coverage On | → Buy |
| 11/02/2018 | 3536.36% | Citigroup | $25 → $28 | Downgrades | Buy → Neutral |
What is the target price for Amarin Corp (AMRN)?
The latest price target for Amarin Corp (NASDAQ: AMRN) was reported by Jefferies on October 25, 2023. The analyst firm set a price target for $1.00 expecting AMRN to rise to within 12 months (a possible 29.87% upside). 4 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Amarin Corp (AMRN)?
The latest analyst rating for Amarin Corp (NASDAQ: AMRN) was provided by Jefferies, and Amarin Corp downgraded their hold rating.
When is the next analyst rating going to be posted or updated for Amarin Corp (AMRN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Amarin Corp, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Amarin Corp was filed on October 25, 2023 so you should expect the next rating to be made available sometime around October 25, 2024.
Is the Analyst Rating Amarin Corp (AMRN) correct?
While ratings are subjective and will change, the latest Amarin Corp (AMRN) rating was a downgraded with a price target of $3.00 to $1.00. The current price Amarin Corp (AMRN) is trading at is $0.77, which is out of the analyst's predicted range.